17 Aug Sources, Risks and Regulatory Requirements of Nitrosamine Impurities in Pharmaceuticals
[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="grid" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" z_index="" css=".vc_custom_1722606248908{margin-left: 10px !important;}" el_class="boxs"][vc_column][vc_column_text] Sources, Risks and Regulatory Requirements of Nitrosamine Impurities in Pharmaceuticals [/vc_column_text][vc_empty_space height="20px"][vc_column_text] Nitrosamines have become a serious pharmaceutical quality and regulatory problem since several nitrosamines are regarded as probable human carcinogens. Their identification in pharmaceuticals...
